Olesoxime (TRO19622) is an investigational neuroprotective small molecule that targets mitochondria. It has demonstrated protective effects in preclinical models of neurodegenerative diseases, including in vitro studies on neuronal cells and in vivo research in animal models of amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA).